Aclarion's CEO Brent Ness to Attend LSI USA 2026 Conference

Thursday, Mar 12, 2026 6:02 am ET1min read
ACON--

Aclarion CEO Brent Ness will attend LSI USA 2026 to discuss the company's progress on NOCISCAN, a proprietary MR spectroscopy platform that uses AI and biomarkers to help physicians identify the source of chronic low back pain. The platform distinguishes between painful and non-painful discs, giving physicians clarity to optimize treatment strategies. The conference is a premier event focused on accelerating MedTech and HealthTech innovation, bringing together investors, startups, and industry leaders.

Aclarion's CEO Brent Ness to Attend LSI USA 2026 Conference

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet